GlassScriptTeleflex Medical Incorporated
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.9Mgeneral payments (2019-2025)
$13Kresearch payments (2019-2025)
55clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Percutaneous: Percuvance System $294K associated (2023-2025)
- Percuvance $215K associated (2023-2025)
- Deknatel $169K associated (2023-2025)
- Titan Sgs Standard Gastric Stapler $42K associated (2023-2025)
- Lma Airway Management $22K associated (2023-2025)
- Titan Sgs $17K associated (2023-2025)
- Weck $2,408 associated (2023-2025)
- Rusch $316 associated (2023-2025)
- Urolift $103 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Sundaram Ravikumar | Dobbs Ferry, NY | Vascular Surgery | $1,753,426.46 |
| Jonathan Thompson | West Chester, OH | Surgery | $56,372.19 |
| John Moenning | Fishers, IN | Oral and Maxillofacial Surgery | $50,989.41 |
| Vipul Patel | Celebration, FL | Urology | $12,750.00 |
| Amol Saxena | Palo Alto, CA | Sports Medicine (Podiatrist) | $8,426.15 |
| Christopher Connor | Boston, MA | Anesthesiology | $3,205.88 |
| Paul Enochs | Cary, NC | Surgery | $2,261.94 |
| Scott Bissell | Bloomfield, CT | Orthopaedic Surgery | $1,500.00 |
| Aaron Hoffman | Dallas, TX | Surgery | $746.09 |
| Erinn Myers | Charlotte, NC | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $600.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.